Sandoz

Sandoz's 2025 integrated report says the company is part of the EU-funded DRAIGON research consortium, which uses AI and genomics to predict resistance and support better treatment decisions, as one of its antimicrobial-resistance research projects.

Partners: DRAIGON consortium